Both in Pharmaceuticals
Equillium vs Organogenesis Holdings
Over the past year EQ returned +5.2% and ORGO returned −80.3%; their daily moves had a correlation of -0.02.
EQ +5.2% ORGO −80.3%Growth of $1, one year, split-adjusted
| Metric | EQ | ORGO |
|---|---|---|
| Price | $1.42 | $0.8255 |
| Market cap | $111.3M | $106.2M |
| Today | 0.00% | +0.10% |
| 1 month | −12.6% | −39.7% |
| 6 months | −30.4% | −64.9% |
| Year to date | −8.4% | −84.1% |
| 1 year | +5.2% | −80.3% |
| Revenue growth (YoY) | — | −56.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −227.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $57.2M | $34.4M |
| Dividend yield | — | — |
| Volatility (60d) | 90.0% | 74.5% |
| Short % of float | 12.6% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).